ubmslateNO-logo-ubm

NO Mobile Logo

Search form

Topics:

Lycored Secures EU Patent for Ingestible Carotenoids for Skincare, UV Protection

Lycored Secures EU Patent for Ingestible Carotenoids for Skincare, UV Protection

Photo © iStockphoto.com/ferlistockphoto

Lycored (Secaucus, NJ) has secured an EU patent for its carotenoid compositions for skin health and UV protection. Specifically, the patent applies to ingestible use of the company’s carotenoid compositions, including its supplement-ready blend Lycoderm, in supplements, food, and beverages.

The company says that its carotenoid blends, which combine natural lycopene with phytoene, phytofluene, and vitamin E from tomatoes, are formulated specifically to protect the skin from UV radiation. The efficacy of these ingredients in protecting skin against harmful radiation was established in an “award-winning” study conducted by Lycored in 2016, it says. The study purportedly found that lycopene-rich tomato nutrition complex and lutein can help protect the skin from UVA, UVB, and UVA1 radiation at a molecular level.

Golan Raz, head of Global Health Division, Lycored, said in a press release: “Lycored is delighted that its carotenoid compositions for skincare have received an EU patent. This is the result of years of hard work and research and further supports our mission to make the benefits of carotenoids as widely available as possible. With consumers increasingly embracing ingestible skincare, and a growing body of evidence for the benefits, we're very excited about the future.”

In addition to the EU patent, the company says that it has held a patent for its carotenoid compositions in Canada since 2014, and has also been granted a patent in Japan. The company is currently awaiting a decision on a pending U.S. patent.

 

 

Also read: 

Lycopene and Lutein Supplements May Protect Skin against Solar Damage

Consumers Think Oral Supplements for Skincare is "Normal," New Lycored Survey Shows

Lycored to Distribute Algatechnologies' Astaxanthin in Beadlet Form

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.